
- /
- Supported exchanges
- / US
- / GPCR.NASDAQ
Structure Therapeutics Inc. American Depositary Shares (GPCR NASDAQ) stock market data APIs
Structure Therapeutics Inc. American Depositary Shares Financial Data Overview
Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral small molecule therapeutics to treat various chronic diseases with unmet medical needs in the United States. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, which is in two phase 2 clinical trials for the treatment of obesity, overweight, and related conditions. The company also develops ACCG-2671, which is in preclinical trial to treat obesity; ANPA-0073, an oral small molecule agonist targeting the apelin, which is phase 2 ready for selective weight loss or muscle-sparing weight loss; and LTSE-2578, an antagonist that targets lysophosphatidic acid 1 receptor, a G-protein coupled receptors implicated in responses to tissue injury and pro-fibrotic processes, for the treatment of idiopathic pulmonary fibrosis. In addition, it develops programs, including glucose-dependent insulinotropic polypeptide receptor (GIPR) program, which identified multiple GIPR agonist, dual GLP-1R/GIPR agonist, and GIPR antagonist hits for small molecule GIPR modulation that has the potential to provide a treatment in obesity; and GCG program, which identified multiple GCG receptor (GCGR) agonist and dual GLP-1R/GCGR agonist hits for small molecule GCGR modulation. The company was formerly known as ShouTi Inc. Structure Therapeutics Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Structure Therapeutics Inc. American Depositary Shares data using free add-ons & libraries
Get Structure Therapeutics Inc. American Depositary Shares Fundamental Data
Structure Therapeutics Inc. American Depositary Shares Fundamental data includes:
- Net Revenue:
- EBITDA: -181 476 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
Get Structure Therapeutics Inc. American Depositary Shares Earnings data
What’s included:
- Latest Release: 2025-05-08
- EPS/Forecast: -0.25
Get Structure Therapeutics Inc. American Depositary Shares End-of-day data
EOD Historical Data package for
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Structure Therapeutics Inc. American Depositary Shares News

We Think Structure Therapeutics (NASDAQ:GPCR) Can Afford To Drive Business Growth
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining exploration companies often lose money for years before finding success with a new ...


Jefferies Reiterates a Buy Rating on Structure Therapeutics (GPCR) With a $79 PT
Structure Therapeutics Inc. (NASDAQ:GPCR) is one of the 13 Small Cap Stocks Analysts Are Bullish On. Jefferies analyst Roger Song maintained a Buy rating on Structure Therapeutics Inc. (NASDAQ:GPCR) o...

Structure Therapeutics' SWOT analysis: oral GLP-1 stock poised for growth
Structure Therapeutics Inc. (NASDAQ:GPCR), a biopharmaceutical company specializing in the development of oral treatments for diabetes and obesity, has been making waves in the competitive GLP-1 recep...

Structure Therapeutics stock maintains JMP rating ahead of key data
Investing.com - JMP Securities maintained its Market Outperform rating and $89.00 price target on Structure Therapeutics (NASDAQ:GPCR) Monday. According to InvestingPro data, analysts’ price targets...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.